Ferric carboxymaltose 1g/20ml dispersion for injection vials
NHS hospitals in England used £30,474,229 of indicative cost of Ferric carboxymaltose 1g/20ml dispersion for injection vials in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is up 0.9% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Ferric carboxymaltose 1g/20ml dispersion for injection vials: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Ferric carboxymaltose 1g/20ml dispersion for injection vials most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Manchester University Nhs Ft | £1,329,231 |
| Oxford University Hospitals Nhs Ft | £1,029,639 |
| Frimley Health Nhs Foundation Trust | £930,624 |
| Derby Teaching Hospitals Nhs Found Trust | £816,494 |
| Imperial College Healthcare Nhs Trust | £754,647 |
| King's College Hpl Nhs Foundation Trust | £752,488 |
| London North West Healthcare Nhs Trust | £752,025 |
| Univ Hpl B/Ham Nhs Foundation Trust | £711,309 |
| Lewisham And Greenwich Nhs Trust | £704,831 |
| Southend Univ Hosp Nhs Foundation Trust | £659,642 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.